Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
295 employees
ViewRay Inc., a Cleveland-based MedTech firm, innovates in radiation therapy for global cancer treatment.
HQ
Founded
2004
ViewRay Inc., a Cleveland-based MedTech firm, innovates in radiation therapy for global cancer treatment. The company develops advanced radiation therapy systems that simultaneously image and treat cancer patients, enhancing precision and effectiveness. ViewRay aims to revolutionize cancer care with cutting-edge technology.
ViewRay has made significant strides in the medical technology sector, impacting cancer treatment worldwide. Their pioneering systems have been adopted by numerous healthcare providers, improving patient outcomes. The company's innovative approach has garnered attention and support from leading medical professionals and investors.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Radiation Therapy
Technology
Analytics, HealthTech
Tags
Medical Devices
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was ViewRay founded?
ViewRay was founded in 2004.
Where is ViewRay's headquarters located?
ViewRay's headquarters is located in DE, US.
When was ViewRay's last funding round?
ViewRay's most recent funding round was for $125M (USD) in November 2022.
How many employees does ViewRay have?
ViewRay has 295 employees as of Feb 5, 2024.
How much has ViewRay raised to-date?
As of July 05, 2023, ViewRay has raised a total of $877.8M (USD) since Nov 14, 2022.
Add Comparison
Total Raised to Date
$877.8M
USD
Last Update Nov 14, 2022
Last Deal Details
$125M
USD
Nov 14, 2022
Post Ipo Debt
Current Employees
295
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts